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Genotypic Characterization of C. glabrata After 
Exposure to Fluconazole 
L.P. SAMARANAYAKE1, Y.H. SAMARANAYAKE2, G. LUO2, B.P.K. CHEUNG2, and J.Y.Y. YAU2, 
1University of Hong Kong, Prince Philip Dental Hospital, Hong Kong, 2University of Hong Kong, 
Hong Kong  
Candida glabrata, has emerged as a major pathogen in HIV-infected patients with oropharyngeal 
candidiasis. This is mainly due to drug resistance acquired with prophylactic use of fluconazole. 
However, mechanisms for fluconazole resistance in C. glabrata are not properly understood. 
Objective: To determine genotypic changes associated with fluconazole exposure in a C. glabrata 
strain. Methods: C. glabrata ATCC2001 was grown on SDA and resuspended in PBS to reach a 
cell concentration of 108 cells/ml. The cells were pelleted and grown in 20 ml RPMI broth 
overnight at 370C, and subsequently exposed to fluconazole MIC concentrations (x1 and x2) for 
60 min. Control tests were carried out without the drug. The karyotipic changes in C. glabrata 
were analyzed with randomly amplified polymorphic DNA (RAPD), restriction fragment length 
polymorphism (RFLP) and, contour-clamped homogenous electric field electrophoresis (CHEF) 
techniques. Results: 1. C. glabrata treated with (x2) MIC fluconazole demonstrated varying 
electrophoretic patterns with 6 of 8 primers used with RAPD whereas no changes were seen with 
(x1) MIC of the drug; 2. RFLP analysis showed changes in the genomic profile (around 700-2500 
bp) with 2 of 4 restriction enzymes (Dde I and Hae III) and, 3. CHEF analysis failed to show any 
positive results. Conclusion: Considering the changes noted in the genotypic profile of the yeast 
isolate pre-treated with fluconazole, it could be said that long term prophylaxis with this drug 
may lead to chromosomal instability in C. glabrata. (Supported by the Research Grants Council 
and the Committee of Research and Conference grants, University of Hong Kong, Hong Kong 
SAR, and the Outstanding Researcher Award of LPS).  
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